242 related articles for article (PubMed ID: 28994145)
1. Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania.
Guarino M; Tortora R; de Stefano G; Coppola C; Morisco F; Salomone Megna A; Izzo F; Nardone G; Piai G; Adinolfi LE; D'Adamo G; Gaeta GB; Messina V; Francica G; De Girolamo V; Coppola N; Persico M; Di Costanzo GG;
J Gastroenterol Hepatol; 2018 May; 33(5):1123-1130. PubMed ID: 28994145
[TBL] [Abstract][Full Text] [Related]
2. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study.
Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R;
Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477
[TBL] [Abstract][Full Text] [Related]
3. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.
Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F;
Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434
[TBL] [Abstract][Full Text] [Related]
4. Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina.
Piñero F; Marciano S; Fernández N; Silva J; Zambelo Y; Cobos M; Zerega A; Ridruejo E; Miguez C; Ameigeiras B; D'Amico C; Gaite L; Coronel M; Bermúdez C; Rosales C; Romero G; McCormack L; Reggiardo V; Colombato L; Gadano A; Rubinstein F; Silva M;
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):376-383. PubMed ID: 29509603
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate.
Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z
J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986
[TBL] [Abstract][Full Text] [Related]
6. HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.
Wallace MC; Huang Y; Preen DB; Garas G; Adams LA; MacQuillan G; Tibballs J; Ferguson J; Samuelson S; Jeffrey GP
Dig Dis Sci; 2017 Aug; 62(8):2182-2192. PubMed ID: 28547649
[TBL] [Abstract][Full Text] [Related]
7. Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.
Richani M; Kolly P; Knoepfli M; Herrmann E; Zweifel M; von Tengg-Kobligk H; Candinas D; Dufour JF
Ann Hepatol; 2016; 15(1):82-90. PubMed ID: 26626644
[TBL] [Abstract][Full Text] [Related]
8. Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations.
Sangiovanni A; Triolo M; Iavarone M; Forzenigo LV; Nicolini A; Rossi G; La Mura V; Colombo M; Lampertico P
Liver Int; 2018 Sep; 38(9):1624-1634. PubMed ID: 29791968
[TBL] [Abstract][Full Text] [Related]
9. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
[TBL] [Abstract][Full Text] [Related]
10. Adherence to the modified Barcelona Clinic Liver Cancer guidelines: Results from a high-volume liver surgery center in East Asias.
Yen YH; Cheng YF; Wang JH; Lin CC; Chen CH; Wang CC
PLoS One; 2021; 16(3):e0249194. PubMed ID: 33765059
[TBL] [Abstract][Full Text] [Related]
11. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter study.
Adhoute X; Pénaranda G; Raoul JL; Blanc JF; Edeline J; Conroy G; Perrier H; Pol B; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Bronowicki JP; Bourlière M
Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):433-40. PubMed ID: 26695429
[TBL] [Abstract][Full Text] [Related]
13. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
14. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
15. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.
Torzilli G; Belghiti J; Kokudo N; Takayama T; Capussotti L; Nuzzo G; Vauthey JN; Choti MA; De Santibanes E; Donadon M; Morenghi E; Makuuchi M
Ann Surg; 2013 May; 257(5):929-37. PubMed ID: 23426336
[TBL] [Abstract][Full Text] [Related]
16. Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice.
Guarino M; Stroffolini T; Lombardo FL; Loperto I; Auriemma F; Gentile I; Caporaso N; Morisco F
J Med Virol; 2015 Aug; 87(8):1368-76. PubMed ID: 25802203
[TBL] [Abstract][Full Text] [Related]
17. Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Giannini EG; Bucci L; Garuti F; Brunacci M; Lenzi B; Valente M; Caturelli E; Cabibbo G; Piscaglia F; Virdone R; Felder M; Ciccarese F; Foschi FG; Sacco R; Svegliati Baroni G; Farinati F; Rapaccini GL; Olivani A; Gasbarrini A; Di Marco M; Morisco F; Zoli M; Masotto A; Borzio F; Benvegnù L; Marra F; Colecchia A; Nardone G; Bernardi M; Trevisani F;
Hepatology; 2018 May; 67(5):1784-1796. PubMed ID: 29159910
[TBL] [Abstract][Full Text] [Related]
18. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A.
Jung YK; Jung CH; Seo YS; Kim JH; Kim TH; Yoo YJ; Kang SH; Yim SY; Suh SJ; An H; Yim HJ; Yeon JE; Byun KS; Um SH
J Gastroenterol Hepatol; 2016 Feb; 31(2):467-74. PubMed ID: 26332049
[TBL] [Abstract][Full Text] [Related]
19. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.
Vitale A; Burra P; Frigo AC; Trevisani F; Farinati F; Spolverato G; Volk M; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Cillo U;
J Hepatol; 2015 Mar; 62(3):617-24. PubMed ID: 25450706
[TBL] [Abstract][Full Text] [Related]
20. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM; Sinn DH; Jung SH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2016 Oct; 36(10):1490-7. PubMed ID: 26936471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
